Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Change in Account Payables (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Change in Account Payables for 15 consecutive years, with -$7.6 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Account Payables fell 160.81% year-over-year to -$7.6 million; the TTM value through Mar 2026 reached $4.9 million, down 68.51%, while the annual FY2025 figure was $25.1 million, 1340.99% up from the prior year.
  • Change in Account Payables hit -$7.6 million in Q1 2026 for Corcept Therapeutics, down from $6.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $12.6 million in Q1 2025 and bottomed at -$7.6 million in Q1 2026.
  • Average Change in Account Payables over 5 years is $1.5 million, with a median of -$165000.0 recorded in 2022.
  • Year-over-year, Change in Account Payables surged 5303.03% in 2023 and then crashed 649.0% in 2024.
  • Corcept Therapeutics' Change in Account Payables stood at $4.2 million in 2022, then tumbled by 84.98% to $637000.0 in 2023, then tumbled by 587.6% to -$3.1 million in 2024, then soared by 293.11% to $6.0 million in 2025, then tumbled by 227.44% to -$7.6 million in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$7.6 million, $6.0 million, and $10.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.